Systems pharmacology reveals the mechanism of Astragaloside IV in improving immune activity on cyclophosphamide-induced immunosuppressed mice
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference64 articles.
1. Tumour necrosis factor and cancer;Balkwill;Nat. Rev. Cancer,2009
2. HIF-1alpha inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment;Borsi;Exp. Cell Res.,2014
3. Alleviative effects of astragaloside IV on cyclophosphamide-induced oxidative damage and immunosuppression in tilapia (Oreochromis niloticus);Cao;Comp. Biochem. Physiol. C Toxicol. Pharmacol.,2023
4. Drug-induced myelosuppression : diagnosis and management;Carey;Drug Saf.,2003
5. Molecular mechanisms of astragaloside-IV in cancer therapy (Review);Chen;Int. J. Mol. Med.,2021
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chinese herbal formula, modified Guilu Erxian glue, alleviates apoptosis of hematopoietic stem cells by regulating SLAM-SAP signal pathway in aplastic anemia mice model;Journal of Ethnopharmacology;2024-12
2. Proteomic and lipidomic analysis of the mechanism underlying astragaloside IV in mitigating ferroptosis through hypoxia-inducible factor 1α/heme oxygenase 1 pathway in renal tubular epithelial cells in diabetic kidney disease;Journal of Ethnopharmacology;2024-11
3. Astragaloside IV Ameliorates Colonic Adenomatous Polyps Development by Orchestrating Gut Bifidobacterium and Serum Metabolome;The American Journal of Chinese Medicine;2024-08-21
4. Danggui Buxue decoction regulates the immune function and intestinal microbiota of cyclophosphamide induced immunosuppressed mice;Frontiers in Pharmacology;2024-08-19
5. Exploration of the underlying mechanism of Astragaloside III in attenuating immunosuppression via network pharmacology and vitro/vivo pharmacological validation;Journal of Ethnopharmacology;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3